TrialBritish journal of cancer2007

Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trial.

V Boige et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.